4.6 Article

Nanoparticle dose and antigen loading attenuate antigen-specific T-cell responses

Related references

Note: Only part of the references are listed.
Article Pharmacology & Pharmacy

Microfluidic-Generated Immunomodulatory Nanoparticles and Formulation-Dependent Effects on Lipopolysaccharide-Induced Macrophage Inflammation

Nhu Truong et al.

Summary: Nanoparticles are a highly promising drug delivery platform with potential applications in controlled drug release, improved targeting, and reduced toxicity. The study developed and optimized a microfluidic method for producing immunomodulatory nanoparticles (iNPs) with anti-inflammatory properties, demonstrating a reproducible strategy for inflammation management.

AAPS JOURNAL (2021)

Article Gastroenterology & Hepatology

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study

Ciaran P. Kelly et al.

Summary: TAK-101, a gluten protein encapsulated in nanoparticles, demonstrated promising results in reducing gluten-induced immune activation in patients with CeD, suggesting a novel approach for other immune-mediated diseases.

GASTROENTEROLOGY (2021)

Article Pharmacology & Pharmacy

Immunomodulatory Nanoparticles Mitigate Macrophage Inflammation via Inhibition of PAMP Interactions and Lactate-Mediated Functional Reprogramming of NF-κB and p38 MAPK

Jackline Joy Martin Lasola et al.

Summary: Inflammation is a crucial process in the body's response to various disease states, and the developed iNPs nanoparticles have demonstrated anti-inflammatory effects through interfering with interactions between pathogen-associated molecular patterns and bone marrow-derived macrophages, among other mechanisms.

PHARMACEUTICS (2021)

Article Gastroenterology & Hepatology

Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease

Tobias L. Freitag et al.

GASTROENTEROLOGY (2020)

Review Nanoscience & Nanotechnology

Overcoming challenges in treating autoimmuntity: Development of tolerogenic immune-modifying nanoparticles

Ryan M. Pearson et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)

Article Biotechnology & Applied Microbiology

Peptide-Conjugated Nanoparticles Reduce Positive Co-stimulatory Expression and T Cell Activity to Induce Tolerance

Robert Kuo et al.

MOLECULAR THERAPY (2017)

Article Biotechnology & Applied Microbiology

Controlled Delivery of Single or Multiple Antigens in Tolerogenic Nanoparticles Using Peptide-Polymer Bioconjugates

Ryan M. Pearson et al.

MOLECULAR THERAPY (2017)

Article Nanoscience & Nanotechnology

An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy

Derrick P. McCarthy et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)

Review Pharmacology & Pharmacy

In vivo reprogramming of immune cells: Technologies for induction of antigen-specific tolerance

Ryan M. Pearson et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Article Biotechnology & Applied Microbiology

Systems Analysis of Dynamic Transcription Factor Activity Identifies Targets for Treatment in Olaparib Resistant Cancer Cells

Joseph T. Decker et al.

BIOTECHNOLOGY AND BIOENGINEERING (2017)

Review Engineering, Biomedical

Immune Tolerance for Autoimmune Disease and Cell Transplantation

Xunrong Luo et al.

ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 18 (2016)

Article Nanoscience & Nanotechnology

Nanoparticle-Based Mucosal Vaccines Targeting Tumor-Associated Antigens to Human Dendritic Cells

R. Brito Baleeiro et al.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)

Article Biochemistry & Molecular Biology

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E. Ritchie et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Multidisciplinary Sciences

Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance

Roberto A. Maldonado et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Review Immunology

Exploiting Apoptosis for Therapeutic Tolerance Induction

Daniel R. Getts et al.

JOURNAL OF IMMUNOLOGY (2013)

Article Cell Biology

Antigen-Specific Tolerance by Autologous Myelin Peptide-Coupled Cells: A Phase 1 Trial in Multiple Sclerosis

Andreas Lutterotti et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

Article Biochemistry & Molecular Biology

The Immunoproteasomes Regulate LPS-Induced TRIF/TRAM Signaling Pathway in Murine Macrophages

Julia Reis et al.

CELL BIOCHEMISTRY AND BIOPHYSICS (2011)

Article Immunology

Antigen-Fixed Leukocytes Tolerize Th2 Responses in Mouse Models of Allergy

Charles B. Smarr et al.

JOURNAL OF IMMUNOLOGY (2011)

Article Multidisciplinary Sciences

Dynamic, Large-Scale Profiling of Transcription Factor Activity from Live Cells in 3D Culture

Michael S. Weiss et al.

PLOS ONE (2010)

Article Multidisciplinary Sciences

ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms

Xunrong Luo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Review Immunology

Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease

Stephen D. Miller et al.

NATURE REVIEWS IMMUNOLOGY (2007)

Article Pharmacology & Pharmacy

Inhibition of nuclear factor-κB enhances the capacity of immature dendritic cells to induce antigen-specific tolerance in experimental autoimmune encephalomyelitis

Mirentxu I. Iruretagoyena et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)

Review Biochemistry & Molecular Biology

Activities of IRF-1

A Kroger et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)

Article Immunology

DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope

JM Robertson et al.

JOURNAL OF IMMUNOLOGY (2000)